Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers. Called CancerSpot, the test uses the latest globally accepted methylation profiling technology to iden
The Institute of Psychiatry, Psychology, and Neuroscience (IoPPN) at King's College London has developed a blood-based test that can predict the risk of Alzheimer's disease up to 3.5 years before clinical diagnosis.